CureVac turns up the heat in ongoing patent litigation with Pfizer
CureVac adds one more patent to the growing tally in its counterclaim against Pfizer and BioNTech in the US.
CureVac adds one more patent to the growing tally in its counterclaim against Pfizer and BioNTech in the US.
What's Your Reaction?
